Featured MNV Articles:
More articles: 1 2 3 4 5 6 7 next »
|Johnson & Johnson Becomes #14 Most Shorted Dow Stock, Replacing Intel
Tuesday, September 27, 9:53 AM ET, by Market News Video Staff
The most recent short interest data has been released for the 09/15/2016 settlement date, and ...
Novo-Nordisk is Oversold
Thursday, September 29, 12:19 PM ET, by Market News Video Staff
The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, ...
5 Dividend Aristocrats Where Analysts See Capital Gains
Friday, September 30, 9:29 AM ET, by Market News Video Staff
To become a "Dividend Aristocrat," a dividend paying company must accomplish an incredible feat: consistently ...
iShares S&P 500 Value ETF Experiences Big Inflow
Friday, September 30, 10:52 AM ET, by Market News Video Staff
Symbols mentioned in this story: IVE, JNJ, USB, TWX Exchange traded funds (ETFs) trade just ...
Add Up The Parts: PBE Could Be Worth $54
Monday, October 3, 9:41 AM ET, by Market News Video Staff
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, ...
JNJ Trading Below Director's Recent Buy Price
By Dividend Channel Staff, Monday, November 28, 11:37 AM ET
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on August 8, Johnson & Johnson's Director, William D. Perez, invested $61,850.00 into 1,000 shares of JNJ, for a cost per share of $61.85. Bargain hunters tend to pay particular attention to insider buys like this one, because presumably the only reason an insider would take their hard-earned cash and use it to buy stock of their company in the open market, is that they expect to make money.
In trading on Monday, bargain hunters could buy shares of Johnson & Johnson (NYSE:JNJ) and achieve a cost basis even cheaper than Perez, with shares changing hands as low as $61.78 per share. It should be noted that Perez has collected $1.14/share in dividends since the time of their purchase, so they are currently up 1.7% on their purchase from a total return basis. Johnson & Johnson shares are currently trading up about 2.2% on the day. The chart below shows the one year performance of JNJ shares, versus its 200 day moving average:
Looking at the chart above, JNJ's low point in its 52 week range is $57.50 per share, with $68.05 as the 52 week high point — that compares with a last trade of $62.57. By comparison, below is a table showing the prices at which insider buying was recorded over the last six months:
||William D. Perez
||William D. Perez
||William D. Perez
The current annualized dividend paid by Johnson & Johnson is $2.28/share, currently paid in quarterly installments, and its most recent dividend ex-date was on 11/25/2011. Below is a long-term dividend history chart for JNJ, which can be of good help in judging whether the most recent dividend with approx. 3.7% annualized yield is likely to continue.
According to the ETF Finder at ETF Channel, JNJ makes up 24.54% of the Pharmaceutical HOLDRS ETF (NASDAQ:PPH) which is trading higher by about 2.5% on the day Monday.
See what other ETFs contain JNJ »
See what other stocks are held by PPH »
JNJ operates in the Drugs & Pharmaceuticals sector, among companies like Corcept Therapeutics Inc (NASDAQ:CORT) which is up about 3.7% today, and Cadence Pharmaceuticals Inc (CADX) trading higher by about 3.9%. Below is a three month price history chart comparing the stock performance of JNJ, versus CORT and CADX.
Free Trial: ''ETF CHANNEL FLEXIBLE GROWTH INVESTMENT PORTFOLIO''
The ETF Channel Flexible Growth Investment Portfolio is designed to seek growth for investors —
anywhere and everywhere. The key to the program is our portfolio strategy allows us complete flexibility in terms of asset
allocation as there are no predetermined guidelines as to the level of stocks, bonds, cash, regions, countries, sectors,
commodities, or even asset classes in the portfolio! In short, this is a completely flexible portfolio designed to follow
the performance trail wherever it leads us.
This Article's Word Cloud: